Internal Medicine, Infectious Disease · Houston, TX
NPI
1386881993
Since 2009
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
3
Medicare group memberships
Hospitals
4
Hospital affiliations
18333 Egret Bay Blvd Ste 140
Houston, TX, 77058
Phone (281) 332-3001
Groups this clinician bills Medicare through
Medicare paid, 2024
$119K
1,448 services
Medicare patients, 2024
311
Average age 74
Drug cost, 2024
$180K
348 prescriptions
Company payments, 2025
$122
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Emmanuel E Okon was code 99232 (hospital e&m - subsequent), 749 times for 198 patients. In total Emmanuel E Okon billed 1,448 services in 13 codes, and Medicare paid $119K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-10-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 749 | 198 | $61.64 | $46K |
| 99233 Hospital E&M - Subsequent | Facility | 318 | 154 | $95.36 | $30K |
| 99223 Hospital E&M - Initial | Facility | 227 | 209 | $136.15 | $31K |
| 99214 Office E&M - Established | Facility | 79 | 68 | $73.48 | $5,805 |
| 99231 Hospital E&M - Subsequent | Facility | 31 | 13 | $38.71 | $1,200 |
| 99204 Office E&M - New | Facility | 11 | 11 | $104.83 | $1,153 |
| 99205 Office E&M - New | Facility | 11 | 11 | $143.39 | $1,577 |
By year: 2022 $147K for 1,994 services; 2023 $143K for 1,742 services; 2024 $119K for 1,448 services.
Medicare prescription drug claims, 2024
In 2024, the drug Emmanuel E Okon prescribed most often to Medicare patients was Ceftriaxone (Ceftriaxone Sodium), with 49 prescriptions and refills. In total Emmanuel E Okon wrote 348 Medicare prescriptions that cost $180K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ceftriaxone Ceftriaxone Sodium | 49 | 49 | 13 | $8,618 |
| Cephalexin Generic | 34 | 50 | 11 | $933 |
| Doxycycline Hyclate Generic | 28 | 48 | Under 11 | $1,012 |
| Daptomycin Generic | 27 | 27 | Under 11 | $7,888 |
| Nafcillin Sodium Generic | 20 | 20 | Under 11 | $14K |
| Fluconazole Generic | 19 | 23 | Under 11 | $827 |
| Cefazolin Sodium Generic | 15 | 15 | Under 11 | $740 |
| Ampicillin Sodium Generic | 13 | 13 | Under 11 | $2,434 |
| Ritonavir Generic | 12 | 12 | Under 11 | $2,496 |
| Descovy Emtricitabine/Tenofov Alafenam | 12 | 12 | Under 11 | $26K |
| Sodium Chloride 0.9 % Sodium Chloride | 11 | 11 | Under 11 | $72.14 |
| Darunavir Generic | 11 | 11 | Under 11 | $19K |
| Ertapenem Ertapenem Sodium | 11 | 11 | Under 11 | $5,578 |
Brand drugs: 42 claims; generic drugs: 306 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Emmanuel E Okon $122 ($122 in general payments such as food, travel and fees) from 1 company. The largest payer was Shionogi Inc with $122.
| Company | Payments | Amount |
|---|---|---|
| Shionogi Inc 4507.T | 1 | $122 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.